Dr. Terry Dubrow and Heather Dubrow have thoughts about Fit for TV exploring the dark side of The Biggest Loser. “We, like ...

Since COVID, there've been growing initiatives in Africa to start producing vaccines and medicines locally, thus gaining greater independence from global supply chains. But are these schemes ...

BioNTech SE is currently sponsoring a Phase II clinical study titled A Phase II, Multisite, Open-label, Single Arm Trial of BNT327 in Combination With Docetaxel in Second-line Stage IV Non-small Cell ...

The NHS has announced that it will fast-track patients with advanced head and neck cancers in England into a clinical trial of an investigational cancer vaccine. Over 100 patients will be matched to ...

BioNTech (BNTX) recently experienced a 10% price increase in the last quarter, coinciding with the Health Canada's authorization of its variant-adapted COMIRNATY COVID-19 vaccine, a potential positive ...

Pfizer said Health Canada has approved its latest COVID-19 vaccine that targets a new Omicron variant. It will be made available in the fall.

Released Tuesday, the AAP's recommendations call for routine vaccination of children ages 6 months to 2 years, citing ...

Multiple scientists and doctors have spoken out against this decision, including infectious diseases expert Dr. Thomas A. Russo, who told Newsweek that mRNA vaccines "will be critical when the next, ...

Texas school districts are coming back from summer with a rising number of parents asking for vaccine exemption forms and a ...

Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...

MRNA vaccines are "the most phenomenal medical breakthrough of the 21st century." And the excitement around them means a few grant cancellations—worth about $23 million per program, or less than 3% of ...